Abstract
Sjögren's syndrome (SS) is a systemic autoimmune disease that frequently occurs concomitantly with other systemic connective tissue disorders, including rare and complex diseases such as systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). The presence of SS influences the clinical expression of the other autoimmune diseases, thus offering the unique opportunity to explore the similarities in genetic signatures, as well as common environmental and biologic factors modulating the expression of disease phenotypes. In this review, we will specifically discuss the possibility of defining "SS/ SLE"and "SS/SSc"as distinct subsets within the context of connective tissue diseases with different clinical expression and outcomes, thus deserving an individualised assessment and personalised medical interventions.
Author supplied keywords
Cite
CITATION STYLE
Baldini, C., Arnaud, L., Avcin, T., Beretta, L., Bellocchi, C., Bouillot, C., … Mariette, X. (2022, May 1). Sjögren’s syndrome and other rare and complex connective tissue diseases: An intriguing liaison. Clinical and Experimental Rheumatology. Clinical and Experimental Rheumatology S.A.S. https://doi.org/10.55563/clinexprheumatol/3y0hqs
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.